99 related articles for article (PubMed ID: 17272676)
1. In vitro evidence for a direct antifibrotic role of the immunosuppressive drug mycophenolate mofetil.
Roos N; Poulalhon N; Farge D; Madelaine I; Mauviel A; Verrecchia F
J Pharmacol Exp Ther; 2007 May; 321(2):583-9. PubMed ID: 17272676
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney.
Badid C; Vincent M; McGregor B; Melin M; Hadj-Aissa A; Veysseyre C; Hartmann DJ; Desmouliere A; Laville M
Kidney Int; 2000 Jul; 58(1):51-61. PubMed ID: 10886549
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effect of mycophenolate mofetil on cultured human Tenon fibroblasts.
Heinz C; Hudde T; Heise K; Steuhl KP
Graefes Arch Clin Exp Ophthalmol; 2002 May; 240(5):408-14. PubMed ID: 12073065
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolic acid displays IMPDH-dependent and IMPDH-independent effects on renal fibroblast proliferation and function.
Petrova DT; Brandhorst G; Brehmer F; Gross O; Oellerich M; Armstrong VW
Ther Drug Monit; 2010 Aug; 32(4):405-12. PubMed ID: 20592645
[TBL] [Abstract][Full Text] [Related]
5. Effects of the immunosuppressant rapamycin on the expression of human α2(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblasts.
Tamaki Z; Asano Y; Kubo M; Ihn H; Tada Y; Sugaya M; Kadono T; Sato S
J Dermatol Sci; 2014 Jun; 74(3):251-9. PubMed ID: 24630239
[TBL] [Abstract][Full Text] [Related]
6. Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation.
Azzola A; Havryk A; Chhajed P; Hostettler K; Black J; Johnson P; Roth M; Glanville A; Tamm M
Transplantation; 2004 Jan; 77(2):275-80. PubMed ID: 14742993
[TBL] [Abstract][Full Text] [Related]
7. Effects of mycophenolate mofetil on key pattern of coronary restenosis: a cascade of in vitro and ex vivo models.
Voisard R; Viola S; Kaspar V; Weber CM; von Müller L; Baur R; Gastrock-Balitsch I; Hombach V
BMC Cardiovasc Disord; 2005 May; 5(1):9. PubMed ID: 15890069
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle formulation of mycophenolate mofetil achieves enhanced efficacy against hepatocellular carcinoma by targeting tumour-associated fibroblast.
Yang Z; Zhang L; Zhu H; Zhou K; Wang H; Wang Y; Su R; Guo D; Zhou L; Xu X; Song P; Zheng S; Xie H
J Cell Mol Med; 2021 Apr; 25(7):3511-3523. PubMed ID: 33713546
[TBL] [Abstract][Full Text] [Related]
9. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
Allison AC; Eugui EM
Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil inhibits intimal hyperplasia and attenuates the expression of genes favouring smooth muscle cell proliferation and migration.
Waller JR; Brook NR; Bicknell GR; Murphy GJ; Nicholson ML
Transplant Proc; 2005; 37(1):164-6. PubMed ID: 15808582
[TBL] [Abstract][Full Text] [Related]
11. Modulation of collagen and MMP-1 gene expression in fibroblasts by the immunosuppressive drug rapamycin. A direct role as an antifibrotic agent?
Poulalhon N; Farge D; Roos N; Tacheau C; Neuzillet C; Michel L; Mauviel A; Verrecchia F
J Biol Chem; 2006 Nov; 281(44):33045-52. PubMed ID: 16914544
[TBL] [Abstract][Full Text] [Related]
12. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
[TBL] [Abstract][Full Text] [Related]
13. Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblasts.
Fineschi S; Reith W; Guerne PA; Dayer JM; Chizzolini C
FASEB J; 2006 Mar; 20(3):562-4. PubMed ID: 16410344
[TBL] [Abstract][Full Text] [Related]
14. 2-Methoxyestradiol inhibits bleomycin-induced systemic sclerosis through suppression of fibroblast activation.
Zhu L; Song Y; Li M
J Dermatol Sci; 2015 Jan; 77(1):63-70. PubMed ID: 25465161
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of monocyte/endothelial cell interactions and monocyte adhesion molecule expression by the immunosuppressant mycophenolate mofetil.
Glomsda BA; Blaheta RA; Hailer NP
Spinal Cord; 2003 Nov; 41(11):610-9. PubMed ID: 14569262
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil inhibits regenerative repair in uranyl acetate-induced acute renal failure by reduced interstitial cellular response.
Sun DF; Fujigaki Y; Fujimoto T; Goto T; Yonemura K; Hishida A
Am J Pathol; 2002 Jul; 161(1):217-27. PubMed ID: 12107106
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1.
Shi-Wen X; Denton CP; Dashwood MR; Holmes AM; Bou-Gharios G; Pearson JD; Black CM; Abraham DJ
J Invest Dermatol; 2001 Mar; 116(3):417-25. PubMed ID: 11231316
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolic acid antagonizes the activation of cultured human mesangial cells.
Dubus I; Vendrely B; Christophe I; Labouyrie JP; Delmas Y; Bonnet J; Combe C
Kidney Int; 2002 Sep; 62(3):857-67. PubMed ID: 12164867
[TBL] [Abstract][Full Text] [Related]
19. The immunosuppressive drug mycophenolate mofetil impairs the adhesion capacity of gastrointestinal tumour cells.
Leckel K; Beecken WD; Jonas D; Oppermann E; Coman MC; Beck KF; Cinatl J; Hailer NP; Auth MK; Bechstein WO; Shipkova M; Blaheta RA
Clin Exp Immunol; 2003 Nov; 134(2):238-45. PubMed ID: 14616783
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the CXC-chemokine expression profile on tumor cells by the immunosuppressive drug mycophenolate mofetil.
Engl T; Relja B; Natsheh I; Makarevic J; Müller I; Beecken WD; Jonas D; Blaheta RA
Int J Mol Med; 2005 Apr; 15(4):641-7. PubMed ID: 15754026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
